Estimation Of Serum Cholesterol Binding Reserve In Patients With Essential Hypertension
International Journal of Drug Delivery Technology · 16.04.2026 · 16 (13s)
DOI: 10.25258/ijddt.16.13s.8 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.04.2026. Verfasst von Hemant Jha und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Atherosclerosis is a major cause of cardiovascular morbidity and mortality. Serum cholesterol binding reserve (SCBR) reflects the capacity of serum lipoproteins to solubilize additional cholesterol and is considered an indirect marker of reverse cholesterol transport. Reduced SCBR has been linked to increased atherogenic risk.
Objective
To estimate serum cholesterol and SCBR in patients with essential hypertension and to compare the findings with healthy age- and sex-matched controls. Materials and Methodology: The study included 50 patients with essential hypertension and 25 healthy controls. Fasting serum cholesterol was measured by an enzymatic method. SCBR was assessed by incubating serum with crystalline cholesterol and determining the increase in cholesterol concentration after incubation. Statistical analysis was performed to compare mean values between groups and to assess correlations.
Results
Mean serum cholesterol levels were significantly higher in hypertensive patients (208.88 ±37.71 mg/dL) than in controls (186.80 ± 32.01 mg/dL) (p < 0.05). Mean SCBR was markedly lower in hypertensive patients (24.50 ± 6.24 mg/dL) compared to controls (59.72 ± 6.99 mg/dL) (p < 0.001). A strong negative correlation was observed between serum cholesterol and SCBR in hypertensive patients (r = –0.876), whereas a positive correlation was noted in controls (r = +0.706).
Conclusion
Patients with essential hypertension exhibit significantly reduced SCBR despite only modest elevations in serum cholesterol. Reduced SCBR may contribute to accelerated atherogenesis in hypertension and may serve as a better biochemical marker of atherogenic risk than serum cholesterol alone.
Zitieren
APA
Jha, H., Mewada, P., Kumari, J., Pawar, A., Anand, A., Shrivastava, M., & Mewada, S. (2026). Estimation Of Serum Cholesterol Binding Reserve In Patients With Essential Hypertension. International Journal of Drug Delivery Technology, 16(13s). https://doi.org/10.25258/ijddt.16.13s.8
Vancouver
Jha H, Mewada P, Kumari J, Pawar A, Anand A, Shrivastava M, et al. Estimation Of Serum Cholesterol Binding Reserve In Patients With Essential Hypertension. International Journal of Drug Delivery Technology. 2026;16(13s). doi:10.25258/ijddt.16.13s.8
BibTeX
@article{Jha2026,
author = {Jha, Hemant and Mewada, Pushpendra and Kumari, Jayanti and Pawar, Aakanksha and Anand, Akhilesh and Shrivastava, Manish and Mewada, Surendra},
title = {Estimation Of Serum Cholesterol Binding Reserve In Patients With Essential Hypertension},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {13s},
doi = {10.25258/ijddt.16.13s.8}
}
EUVIMED